Introduction

This week, we want to talk about the hoopla around this idea of too much lean mass loss from glucagon-like peptide 1 agonist. This all came about, there have been some papers questioning this and some people on Twitter. Dr. Spencer Nodolsky: "I don't believe anything Peter Atia says"